Crow S, Fischer AC, Schears RM. Extracorporeal life support: utilization, cost, controversy, and ethics of trying to save lives. Semin Cardiothorac Vasc Anesth. 2009;13(3):183–91.
Mavroudis C, Mavroudis CD, Green J, Sade RM, Jacobs JP, Kodish E. Ethical considerations for post-cardiotomy extracorporeal membrane oxygenation. Cardiol Young. 2012;22(6):780–6.
Bartlett RH. Clinical research in acute fatal illness: lessons from extracorporeal membrane oxygenation. J Intensive Care Med. 2016;31(7):456–65.
Combes A, Hajage D, Capellier G, Demoule A, Lavoué S, Guervilly C, Da Silva D, Zafrani L, Tirot P, Veber B, Maury E, Levy B, Cohen Y, Richard C, Kalfon P, Bouadma L, Mehdaoui H, Beduneau G, Lebreton G, Brochard L, Ferguson ND, Fan E, Slutsky AS, Brodie D, Mercat A, EOLIA Trial Group, REVA, and ECMONet. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med. 2018;378(21):1965–75.
Combes A, Price S, Slutsky AS, Brodie D. Temporary circulatory support for cardiogenic shock. Lancet. 2020;396(10245):199–212.
Yannopoulos D, Bartos J, Raveendran G, Walser E, Connett J, Murray TA, Collins G, Zhang L, Kosmopoulos M, Ranjit J, Shaffer A, Frascone RJ, Wesley K, Conterato M, Biros M, Tolar J, Auferheide TP. Advanced reperfusion strategies for patients with out-of-hospital cardiac arrest and refractory ventricular fibrillation (ARREST): a phase 2, single center, open-label, randomised controlled trial. Lancet. 2020;396:1807–16.
Frank HA. Ethics of randomization: use of extracorporeal membrane oxygenation. N Engl J Med. 1977;296(7):397–8.
Chalmers TC. A belated randomized control trial. Pediatrics. 1990;85(3):366–9.
Mike V, Krauss AN, Ross GS. Neonatal extracorporeal membrane oxygenation (ECMO): clinical trials and the ethics of evidence. J Med Ethics. 1993;19(4):212–8.
Lantos JD, Frader J. Extracorporeal membrane oxygenation and the ethics of clinical research in pediatrics. N Engl J Med. 1990;323(6):409–13.
Rosenberger WF, Lachin JM. The use of response-adaptive designs in clinical trials. Control Clin Trials. 1993;14(6):471–84.
Bluhm R. The epistemology and ethics of chronic disease research: further lessons from ECMO. Theor Med Bioeth. 2010;31(2):107–22.
Gattinoni L, Vasques F, Quintel M. Use of ECMO in ARDS: does the EOLIA trial really help? Crit Care. 2018;22(1):171.
Truog RD. Informed consent and research design in critical care medicine. Crit Care. 1999;3(3):R29–33.
Worrall J. Evidence and ethics in medicine. Perspect Biol Med. 2008;51(3):418–31.
Wolfson RK, Kahana MD, Nachman JB, Lantos J. Extracorporeal membrane oxygenation after stem cell transplant: clinical decision-making in the absence of evidence. Pediatr Crit Care Med. 2005;6(2):200–3.
Jaramillo C, Braus N. How should ECMO initiation and withdrawal decisions be shared? AMA J Ethics. 2019;21(5):E387-393.
Abrams D, Combes A, Brodie D. What’s new in extracorporeal membrane oxygenation for cardiac failure and cardiac arrest in adults? Intensive Care Med. 2014;40(4):609–12.
Brauner DJ, Zimmermann CJ. Will we code for default ECMO? AMA J Ethics. 2019;21(5):E443-449.
Kirsch R, Munson D. Ethical and end of life considerations for neonates requiring ECMO support. Semin Perinatol. 2018;42(2):129–37.
Di Nardo M, Ore AD, Testa G, Annich G, Piervincenzi E, Zampini G, Bottari G, Cecchetti C, Amodeo A, Lorusso R, Del Sorbo L, Kirsch R. Principlism and personalism. Comparing two ethical models applied clinically in neonates undergoing extracorporeal membrane oxygenation support. Front Pediatr. 2019;30(7):312.
Ting PS, Chen L, Yang WC, Huang TS, Wu CC, Chen YY. Gender and age disparity in the initiation of life-supporting treatments: a population-based cohort study. BMC Med Ethics. 2017;18(1):62.
Cronin AJ. End-of-life care in advanced kidney disease: ethical and legal issues and key challenges for black and minority ethnic groups. J Ren Care. 2014;1(40 Suppl):16–22.
Kissoon N, Bohn D. Use of extracorporeal technology during pandemics: ethical and staffing considerations. Pediatr Crit Care Med. 2010;11(6):757–8.
Cheruku S, Dave S, Goff K, Park C, Ebeling C, Cohen L, Styrvoky K, Choi C, Anand V, Kershaw C. Cardiopulmonary resuscitation in intensive care unit patients with coronavirus disease 2019. J Cardiothorac Vasc Anesth. 2020;34(10):2595–603.
Supady A, Bode C, Duerschmied D. Procedural justice and egalitarian principles for rationing decisions in the COVID-19 crisis. Crit Care. 2020;24(1):590.
Tyrrell CSB, Mytton OT, Gentry SV, Thomas-Meyer M, Allen JLY, Narula AA, McGrath B, Lupton M, Broadbent J, Ahmed A, Mavrodaris A, Ahmed A, Pari A. Managing intensive care admissions when there are not enough beds during the COVID-19 pandemic: a systematic review. Thorax. 2021;76:302–12.
Supady A, Curtis JR, Abrams D, Lorusso R, Bein T, Boldt J, Brown CE, Duerschmied D, Metaxa V, Brodie D. Allocating scarce intensive care resources during the COVID-19pandemic: practical challenges to theoretical frameworks. Lancet Respir Med. 2021;9:430–4.
DeLaney E, Smith MJ, Harvey BT, Pelletier KJ, Aquino MP, Stone JM, Jean-Baptiste GC, Johnson JH. Extracorporeal life support for pandemic influenza: the role of extracorporeal membrane oxygenation in pandemic management. J Extra Corpor Technol. 2010;42(4):268–80.
MacGregor RM, Antiel RM, Najaf T, Said AS, Warner BW, Raval MV, Shakhsheer B. Extracorporeal membrane oxygenation for pediatric patients with coronavirus disease 2019-related illness. Pediatr Crit Care Med. 2020;21(10):893–7.
Bein T, Brodie D. Understanding ethical decisions for patients on extracorporeal life support. Intensive Care Med. 2017;43(10):1510–1.
Simons J, Suverein M, van Mook W, Caliskan K, Soliman O, van de Poll M, Delnoij T, Maessen J, Mees B, Lorusso R. Do-(not-)mechanical-circulatory-support orders: should we ask all cardiac surgery patients for informed consent for post-cardiotomy extracorporeal life circulatory support? J Clin Med. 2021;10:383.
Peetz AB, Sadovnikoff N, O’Connor MF. Is informed consent for extracorporeal life support even possible? AMA J Ethics. 2015;17(3):236–42.
DeMartino ES, Braus NA, Sulmasy DP, Bohman JK, Stulak JM, Guru PK, Fuechtmann KR, Singh N, Schears GJ, Mueller PS. Decisions to withdraw extracorporeal membrane oxygenation support: patient characteristics and ethical considerations. Mayo Clin Proc. 2019;94(4):620–7.
Meltzer EC, Ivascu NS, Stark M, Orfanos AV, Acres CA, Christos PJ, Mangione T, Fins JJ. A survey of physicians’ attitudes toward decision-making authority for initiating and withdrawing VA-ECMO: results and ethical implications for shared decision making. J Clin Ethics. 2016;27(4):281–9.
Abrams D, Pham T, Burns KEA, Combes A, Curtis JR, Mueller T, Prager KM, Serra A, Slutsky AS, Brodie D, Schmidt M, International ECMO Network (ECMONet). Practice patterns and ethical considerations in the management of venovenous extracorporeal membrane oxygenation patients: an international survey. Crit Care Med. 2019;47(10):1346–55.
Whitman GJR. Extracorporeal membrane oxygenation for the treatment of postcardiotomy shock. J Thorac Cardiovasc Surg. 2017;153(1):95–101.
Abrams DC, Prager K, Blinderman CD, Burkart KM, Brodie D. Ethical dilemmas encountered with the use of extracorporeal membrane oxygenation in adults. Chest. 2014;145(4):876–82.
Mulaikal TA, Nakagawa S, Prager KM. Extracorporeal membrane oxygenation bridge to no recovery. Circulation. 2019;139(4):428–30.
Mancini ME, Diekema DS, Hoadley TA, Kadlec KD, Leveille MH, McGowan JE, Munkwitz MM, Panchal AR, Sayre MR, Sinz EH. Part 3: ethical issues: 2015 American Heart Association guidelines update for cardiopulmonary resuscitation and emergency cardiovascular care. Circulation. 2015;132(18 Suppl 2):383–96.
Fuehner T, Kuehn C, Welte T, Gottlieb J. ICU care Before and after lung transplantation. Chest. 2016;150(2):442–50.
Truog RD, Thiagarajan RR, Harrison CH. Ethical dilemmas with the use of ECMO as a bridge to transplantation. Lancet Respir Med. 2015;3(8):597–8.
Paris JJ, Schreiber MD. Physicians’ refusal to provide life-prolonging medical interventions. Clin Perinatol. 1996;23(3):563–71.
Gamulka BD. Ethical uncertainty: an approach to decisions involving extracorporeal membrane oxygenation. CMAJ. 1994;150(4):565–8.
Steinhorn DM. Termination of extracorporeal membrane oxygenation for cardiac support. Artif Organs. 1999;23(11):1026–30.
Courtwright AM, Robinson EM, Feins K, Carr-Loveland J, Donahue V, Roy N, McCannon J. Ethics committee consultation and extracorporeal membrane oxygenation. Ann Am Thorac Soc. 2016;13(9):1553–8.
Shemie SD. Clarifying the paradigm for the ethics of donation and transplantation: was ‘dead’ really so clear before organ donation? Philos Ethics Humanit Med. 2007;24(2):18.
Baker A, Shemie SD. Biophilosophical basis for identifying the death of a person. J Crit Care. 2014;29(4):687–9.
Dalle Ave AL, Bernat JL. Donation after brain circulation determination of death. BMC Med Ethics. 2017;18(1):15.
Hayes D Jr, Black SM, Whitson BA. Extracorporeal membrane oxygenation in pediatric organ donation. Pediatr Transplant. 2014;18(5):549–50.
Verheijde JL, Rady MY, McGregor J. Presumed consent for organ preservation in uncontrolled donation after cardiac death in the united states: a public policy with serious consequences. Philos Ethics Humanit Med. 2009;4:15.
Shapey IM, Summers A, Augustine T, van Dellen D. Systematic review to assess the possibility of return of cerebral and cardiac activity after normothermic regional perfusion for donors after circulatory death. Br J Surg. 2019;106(3):174–80.
Dalle Ave AL, Bernat JL. Uncontrolled donation after circulatory determination of death: a systematic ethical analysis. J Intensive Care Med. 2018;33(11):624–34.
Bernat JL, Capron AM, Bleck TP, Blosser S, Bratton SL, Childress JF, DeVita MA, Fulda GJ, Gries CJ, Mathur M, Nakagawa T, Rushton CH, Shemie SD, White DB. The circulatory-respiratory determination of death in organ donation. Crit Care Med. 2010;38(3):963–70.
Halpern SD, Truog RD. Organ donors after circulatory determination of death: not necessarily dead, and it does not necessarily matter. Critical Care Med. 2010;38(3):1011–2.
Dalle Ave AL, Shaw DM, Bernat JL. Ethical issues in the use of extracorporeal membrane oxygenation in controlled donation after circulatory determination of death. Am J Transplant. 2016;16(8):2293–9.
Glannon W. The moral insignificance of death in organ donation. Camb Q Healthc Ethics. 2013;22(2):192–202.
Wall SP, Munjal KG, Dubler NN, Goldfrank LR, NYC uDCDD Study Group. Uncontrolled organ donation after circulatory determination of death: US policy failures and call to action. Ann Emerg Med. 2014;63(4):392–400.
Molina M, Domínguez-Gil B, Pérez-Villares JM, Andrés A. Uncontrolled donation after circulatory death: ethics of implementation. Curr Opin Organ Transplant. 2019;24(3):358–63.
Balsorano P, Ciapetti M, Cianchi G, Bonizzoli M, Migliaccio ML, Ferraro MC, Franci A, Peris A. Extracorporeal life support and multiorgan donation in a severe polytrauma patient: a case report. Int J Surg Case Rep. 2015;9:109–11.
Dalle Ave AL, Shaw DM, Gardiner D. Extracorporeal membrane oxygenation (ECMO) assisted cardiopulmonary resuscitation or uncontrolled donation after the circulatory determination of death following out-of-hospital refractory cardiac arrest-An ethical analysis of an unresolved clinical dilemma. Resuscitation. 2016;108:87–94.
Dalle Ave AL, Gardiner D, Shaw DM. The ethics of extracorporeal membrane oxygenation in brain-dead potential organ donors. Transpl Int. 2016;29(5):612–8.
Ortega-Deballon I, Hornby L, Shemie SD. Protocols for uncontrolled donation after circulatory death: a systematic review of international guidelines, practices and transplant outcomes. Crit Care. 2015;19(1):268.
Bernat JL. The boundaries of organ donation after circulatory death. N Engl J Med. 2008;359(7):669–71.
Carlisle EM, Loeff DS. Emerging issues in the ethical utilization of pediatric extracorporeal membrane oxygenation. Curr Opin Pediatr. 2020;32(3):411–5.
Abrams D, Lorusso R, Vincent JL, Brodie D. ECMO during the COVID-19 pandemic: when is it justified? Crit Care. 2020;24(1):507.
Ross LF. Respecting choice in definitions of death. Hastings Cent Rep. 2018;48(Suppl 4):53–5.